You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: Specialist programmes and second-generation antipsychotics reduce relapse after first-episode psychosis

http://dx.doi.org/10.1136/ebmh.2011.100098

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Question

    Question

    Are pharmacological and non-pharmacological interventions effective in preventing relapse in first-episode psychosis (FEP) patients?

    Outcomes

    The primary outcome was relapse, defined according to the criteria used in the individual studies.

    Methods

    Design

    Systematic review and meta-analysis.

    Data sources

    CENTRAL, MEDLINE, MEDLINE Unindexed, EMBASE, PsycINFO, UMI Proquest Digital Dissertations, Information Science Citation Index Expanded, Information Social Sciences Citation Index, and Information Arts and Humanities Citation Index were searched from inception to December 2008. Additional studies were also identified using conference abstracts from ISI Science and Technology Proceedings and ISI Information Social Science and Humanities proceeding; hand searching of reference lists of retrieved trials, previous reviews and meeting abstracts; and contact with researchers and experts in the field.

    Study selection and analysis

    Randomised controlled trials (RCTs) of pharmacological and non-pharmacological interventions, where at least 75% of participants experiencing FEP diagnosed according to DSM or ICD criteria were included. A broad definition of FEP was used and could include schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, substance-induced psychotic disorder and psychotic disorder not otherwise …

    View Full Text

    Footnotes

    • Sources of funding Marqués de Valdecilla Public Foundation – Research Institute (FMV-IFIMAV), Santander, Spain; Colonial Foundation; National Health and Medical Research Council of Australia.

    Footnotes

    • Competing interests None.